Prognostic value of immunofluorometrically quantifed P53 protein in ovarian carcinoma
β Scribed by M.A. Levesque; E.P. Diamandis; H. Yu; P. Zola; P. Sismondi; G. Giardina; D. Katsaros
- Book ID
- 107740642
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 130 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0009-9120
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The influence of __p53__ mutations on the response to ionizing radiation and survival was retrospectively evaluated in patients treated with preoperative radiotherapy for rectal carcinoma. From 1989 to 1991, 86 rectal cancer patients treated by preoperative radiotherapy were included in
The p53 tumor suppressor gene has recently been implicated in the pathogenesis of human esophageal cancer. To assess potential clinical applications for this molecular marker, 52 patients with primary esophageal adenocarcinoma were studied prospectively. p53 protein accumulation was evaluated immuno
The prognostic significance and nature of p53 dysfunction in ovarian carcinoma is unclear. The relation between p53 overexpression, p53 mutations, and their effects on overall survival in primary ovarian carcinoma is explored. ## METHODS. Tumor specimens from 171 consecutive epithelial ovarian ca
With regard to prognosis, patients whose tumors had both First Department of Surgery, Nara Medical Unistrong positivity for cyclin E and positivity for p53 had significantly poorer prognosis. versity, Nara, Japan. In multivariate analysis, the combined variable of cyclin E and p53 was an independen